THIOTEPA

9762 reported adverse events

Drug classes: Alkylating Drug [EPC]

THIOTEPA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PRE-ENGRAFTMENT IMMUNE REACTION 47 0.5875
1 AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME 21 0.3559
2 ADENOVIRUS REACTIVATION 40 0.2778
3 VIRAL HAEMORRHAGIC CYSTITIS 149 0.2093
4 DISSEMINATED TOXOPLASMOSIS 24 0.2000
5 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 278 0.1967
6 ENGRAFTMENT SYNDROME 113 0.1912
7 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 464 0.1677
8 HUMAN HERPESVIRUS 6 INFECTION 305 0.1612
9 GASTROENTERITIS ADENOVIRUS 25 0.1592
See all enriched reactions for THIOTEPA